Overall, this study demonstrated the potential of biogenic AgNPs for cancer treatment, while FGF19 and BCL-2 family chemicals showed great promise as tumor therapeutic targets or indicators of tumor disorders, providing hope for targeted tumor therapy. The gene discussed is BCL2; the disease is neoplasm.